TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Generics Pharmaceuticals Transition 2023_1

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Generics Pharmaceuticals Transition 2023_1". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
66.2Bids / Report
11.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 515 active published awards; 512 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published24 May 2023, 14:17 BST
Last source update24 May 2023, 14:17 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-039687
What is being bought
Framework agreement for NHS National Generics Pharmacuticals Transition 2023_1. Offer reference number CM/PHG/22/5666.<br/><br/>Potential periods of call-offs under the framework agreement:<br/> CM/PHG/22/5666/00 – Transition Products:<br/>CESW- /08/2023 – 31/01/2024 (6 months) <br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months) <br/> <br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: <br/>All regions: 01/08/2023 to 31/05/2024 (10 Months)
What changed
From the official release history
  1. tender value changed
    24 May 2023, 14:17 BST
  2. Status changed to complete
    24 May 2023, 14:17 BST
  3. Official notice release published
    24 May 2023, 14:17 BST
  4. Submission deadline changed to published date
    24 May 2023, 14:17 BST
  5. Published value updated to £99,290,712
    11 Jan 2023, 12:11 GMT
  6. Status changed to active
    11 Jan 2023, 12:11 GMT
  7. Official notice release published
    11 Jan 2023, 12:11 GMT
  8. Submission deadline changed to 17 Feb 2023, 13:00 GMT
    11 Jan 2023, 12:11 GMT
  9. Buyer information updated
    11 Jan 2023, 12:11 GMT
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - CM/PHG/22/5666/00 - Supplier offer confirmation (Check box)
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. <br/><br/>CM/PHG/22/5666/00 – Transition Products:<br/>CESW 01/08/2023 – 31/01/2024 (6 months) <br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months) <br/> <br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: <br/>All regions: 01/08/2023 to 31/05/2024 (10 Months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - CM/PHG/22/5666/01 - Supplier offer confirmation (Check box)
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/><br/>CM/PHG/22/5666/00 – Transition Products:<br/>CESW 01/08/2023 – 31/01/2024 (6 months)<br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months)<br/><br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products:<br/>All regions: 01/08/2023 to 31/05/2024 (10 Months)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    24 May 2023, 14:17 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Award active
    Not published · Not published
  36. Award active
    Not published · Not published
  37. Award active
    Not published · Not published
  38. Award active
    Not published · Not published
  39. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  40. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  41. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  42. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  43. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  44. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  45. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  46. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  47. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  48. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  49. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  50. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  51. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  52. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  53. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  54. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  55. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  56. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  57. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  58. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  59. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  60. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  61. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  62. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  63. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  64. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  65. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  66. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  67. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  68. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  69. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  70. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  71. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  72. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  73. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  74. Contract active
    Signed 5 May 2023, 00:00 BST · £1
  75. Contract active
    Signed 5 May 2023, 00:00 BST · £1
Commercial outcome and competition
Awards
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Sun Pharma UK Ltd
Not published · Not published · active
Consilient Health Ltd
Not published · Not published · active
Day Lewis Medical Ltd
Not published · Not published · active
Waymade PLC
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Aristo Pharma Limited
Not published · Not published · active
Eramol (UK) Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Roma Pharmaceuticals Limited
Not published · Not published · active
Drugsrus Ltd
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
Fontus Health Ltd
Not published · Not published · active
Ipca Laboratories UK Ltd
Not published · Not published · active
Relonchem Ltd
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Strandhaven Ltd t/a Somex Pharma
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Neuraxpharm UK Ltd
Not published · Not published · active
Syri Limited (T/A Thame Laboratories)
Not published · Not published · active
Crescent Pharma Ltd
Not published · Not published · active
Brown and Burk UK Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Resolution Chemicals Limited
Not published · Not published · active
Drugsrus Ltd
Not published · Not published · active
Thea Pharmaceuticals Limited
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Amarox Limited
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Tillomed Laboratories ltd
Not published · Not published · active
Wockhardt UK Limited
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
Contracts
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 2 - CM/PHG/22/5666/01
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Lot 1 - CM/PHG/22/5666/00
£1 · signed 5 May 2023, 00:00 BST · active
Bid statistics
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 21
bids: 16
bids: 16
bids: 16
bids: 16
bids: 21
bids: 16
bids: 16
bids: 16
bids: 16
bids: 16
bids: 16
bids: 16
bids: 16
bids: 16
bids: 16
bids: 21
bids: 16
bids: 16
bids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 21
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 21
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 16
electronicBids: 21
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-67205
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    1st Floor, Quarry House, Quarry Hill, Leeds, UKE, LS2 7UE
    sharron.giblin@nhs.net

  • Accord-UK Ltd
    supplier

    DEVON, UK

  • Amarox Limited
    supplier

    HARROW, UK

  • Aristo Pharma Limited
    supplier

    ELY, UK

  • Aventis Pharma ltd t/a Sanofi
    supplier

    READING, UK

  • Brown and Burk UK Ltd
    supplier

    HOUNSLOW WEST, UK

  • Consilient Health Ltd
    supplier

    RICHAMOND UPONTHAMES, UK

  • Crescent Pharma Ltd
    supplier

    BASINGSTOKE, UK

  • Day Lewis Medical Ltd
    supplier

    CROYDON, UK

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    MILTON, UK

  • Drugsrus Ltd
    supplier

    NORTHWOOD, UK

  • Eramol (UK) Ltd
    supplier

    SEVENOAKS, UK

  • Fontus Health Ltd
    supplier

    WALSALL, UK

  • Ipca Laboratories UK Ltd
    supplier

    SUNDERLAND, UK

  • Milpharm Ltd/aurobinbdo
    supplier

    SOUTH RUISLIP, UK

  • Neuraxpharm UK Ltd
    supplier

    CARDIFF, UK

  • Relonchem Ltd
    supplier

    WIDNES, UK

  • Resolution Chemicals Limited
    supplier

    LONDON, UK

  • Roma Pharmaceuticals Limited
    supplier

    BURTON UPON TRENT, UK

  • Sandoz Ltd
    supplier

    CAMBERLEY, UK

  • Strandhaven Ltd t/a Somex Pharma
    supplier

    ILFORD, UK

  • Sun Pharma UK Ltd
    supplier

    UXBRIDGE, UK

  • Syri Limited (T/A Thame Laboratories)
    supplier

    RUISLIP, UK

  • Teva UK Limited
    supplier

    CASTLEFORD, UK

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL

  • Thea Pharmaceuticals Limited
    supplier

    NEWCASTLE-UNDER-LYME, UK

  • Thornton and Ross Ltd
    supplier

    LINTHWAITE, UK

  • Thornton and Ross Ltd
    supplier

    LYNTHWAITE, UK

  • Tillomed Laboratories ltd
    supplier

    LUTON, UK

  • Waymade PLC
    supplier

    LONDON, UK

  • Wockhardt UK Limited
    supplier

    WREXHAM, UK

  • Zentiva Pharma UK Ltd
    supplier

    LONDON, UK

  • medac Pharma LLP
    supplier

    STIRLING, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published